Common Mistakes in Meta-Analysis and How to Avoid Them

Meta-analysis is a statistical method that quantitatively combines results from multiple studies addressing the same research question. When conducted properly, it can provide more precise estimates than any single study. However, meta-analysis is vulnerable to a range of errors that can produce misleading conclusions. This article identifies the most frequent mistakes researchers make when planning, conducting, and reporting meta-analyses, and provides practical strategies to prevent them. The guidance applies to students, researchers, life-science professionals, and informed general readers who need to evaluate or conduct meta-analytic work.

At a Glance

The table below summarizes the most common mistakes in meta-analysis, their consequences, and the preventive measures discussed throughout this article.

Defining the Research Question and Eligibility Criteria

The foundation of any meta-analysis is a well-defined research question. Without clear eligibility criteria, researchers risk including studies that are too dissimilar to combine meaningfully. The process begins with formulating a specific question using structured frameworks that specify the population, intervention, comparator, and outcomes of interest. This framework guides every subsequent decision in the review process.

Systematic reviews require explicit eligibility criteria developed before the search begins. These criteria should specify the study designs that will be included, the characteristics of participants, the types of interventions or exposures, and the outcomes that will be measured. A priori specification of subgroup hypotheses is essential to avoid post hoc analyses that capitalize on chance findings. When researchers define their question and eligibility criteria after seeing the data, they risk introducing bias into the review process.

The research question should be generated from information not used later in the meta-analysis. This separation prevents the question from being shaped by the results of the included studies. Researchers should document their question and eligibility criteria in a protocol before conducting the search. This protocol serves as a reference point for evaluating whether the review was conducted as planned.

Comprehensive Literature Searching

A meta-analysis is only as good as the studies it includes. Incomplete searches lead to missing relevant studies, which can bias the results. Many researchers make the mistake of searching only one or two databases, which may not capture all relevant literature.

Comprehensive literature searches should cover multiple databases including PubMed, Embase, and the Cochrane Library. Each database indexes different journals and has different coverage, so relying on a single database risks missing important studies. The search strategy should combine controlled vocabulary terms with free-text terms to maximize sensitivity.

Manual searching of reference lists is mandatory. This process involves examining the reference lists of included studies and relevant review articles to identify additional studies that may have been missed by the database searches. Citation tracking, where researchers identify studies that have cited key articles, can also uncover relevant work.

The NCBI Literature Resources provide access to PubMed and other databases that are essential for comprehensive searching. PubMed, maintained by the National Library of Medicine, indexes millions of biomedical articles and is a primary resource for literature searching. However, researchers should not rely on PubMed alone, as it does not index all relevant journals in every field.

The modern file drawer problem extends beyond unpublished studies. Nonsignificant outcomes and secondary outcomes such as adverse events are often omitted from abstracts due to word limits or pressure to publish. Academic databases index limited metadata but not the full text, making outcomes that are not reported in the abstract resistant to search. This creates a situation where findings are available in full text but remain inaccessible to search, leading to overestimated treatment effects and biased reported complication rates in systematic reviews and meta-analyses. Researchers should search full-text sources and consider contacting study authors for unreported outcomes.

Study Selection and Screening

The selection of studies should be conducted by two investigators independently. This dual screening process reduces the risk of errors and ensures that decisions about inclusion are reproducible. Disagreements between reviewers should be resolved through discussion or by consulting a third reviewer.

Screening typically occurs in two stages. The first stage involves screening titles and abstracts to identify potentially relevant studies. The second stage involves reviewing the full text of potentially relevant studies to determine whether they meet the eligibility criteria. Each stage should be documented, with reasons for exclusion recorded at the full-text stage.

Tools like EndNote and Covidence streamline reference management and study selection, enhancing efficiency and accuracy. These tools allow reviewers to track decisions, manage duplicates, and document the screening process. The screening process should be reported transparently in the final review, typically using a flow diagram that shows the number of records identified, screened, excluded, and included.

Conventional screening methods have limitations. The pitfalls of conventional methods of screening for systematic reviews include the challenge of identifying studies where relevant outcomes are not mentioned in the abstract. Researchers should be aware that screening based solely on abstracts may miss studies that report relevant outcomes in the full text but not in the abstract.

Risk of Bias Assessment

Risk of bias assessment is mandatory when performing a meta-analysis. This assessment provides an overview of the quality of the studies from which data are extracted. Several tools have been developed for this purpose, and the choice of tool depends on the study designs included in the review.

For randomized controlled trials, the Cochrane Risk of Bias 2 tool is the most commonly used and recommended instrument. This tool evaluates bias across several domains including the randomization process, deviations from intended interventions, missing outcome data, measurement of the outcome, and selection of the reported result. The Jadad scale is another tool used for randomized trials, though it focuses on a narrower set of criteria.

For nonrandomized studies, the Risk Of Bias In Non-randomized Studies tool and the Newcastle-Ottawa Scale are commonly used. The Newcastle-Ottawa Scale assesses the quality of nonrandomized studies in terms of selection of study groups, comparability of groups, and ascertainment of outcomes. However, the Newcastle-Ottawa Scale has been critically evaluated, and researchers should understand its limitations. The tool has been criticized for its lack of clear guidance on how to assess comparability and for the potential for subjectivity in scoring.

Quality assessment using validated tools is crucial to evaluate the methodological rigor of included studies. The results of the risk of bias assessment should be reported for each included study and considered when interpreting the results of the meta-analysis. Studies at high risk of bias may need to be excluded or analyzed separately in sensitivity analyses.

The EQUATOR Network provides reporting guidelines and resources that can help researchers conduct and report their systematic reviews and meta-analyses properly. These resources support transparent and complete reporting, which is essential for the critical appraisal of meta-analytic evidence.

Data Extraction

Data extraction is a critical step where errors can easily occur. Common errors include data entry mistakes, incorrect calculation of effect sizes, and extraction of data from the wrong tables or figures. These errors can lead to incorrect pooled estimates and conclusions.

Data extraction should use standardized forms to ensure consistent information capture. These forms should specify exactly what data will be extracted from each study, including study characteristics, participant characteristics, intervention details, outcome data, and information needed for risk of bias assessment.

Data extraction should be conducted by two researchers independently. This dual extraction process allows discrepancies to be identified and resolved. When the two extractions disagree, the researchers should consult the original study to determine the correct data.

Data entry mistakes are a common source of error in meta-analysis. These mistakes can occur when transferring data from extraction forms to statistical software. Researchers should verify data entry by having a second person check the entered data against the extraction forms. Statistical software such as R and RevMan can compute effect sizes, confidence intervals, and assess heterogeneity, but the accuracy of the output depends on the accuracy of the input data.

Publication Bias and Selective Reporting

Publication bias occurs when studies with statistically significant results are more likely to be published than studies with nonsignificant results. This bias can lead to overestimated treatment effects in meta-analyses because the available literature does not represent all studies that have been conducted.

The file drawer problem describes the situation where studies with nonsignificant results remain unpublished and are effectively hidden from the scientific community. This problem is compounded by selective reporting, where outcomes that are not significant are omitted from published reports. The modern file drawer problem extends to outcomes that are available in full text but not in abstracts, making them resistant to database searches.

Several statistical methods can address publication bias. Funnel plots provide a visual assessment of publication bias by plotting effect sizes against a measure of study precision. Asymmetry in the funnel plot may indicate publication bias, though asymmetry can also result from other factors such as heterogeneity. Egger regression provides a statistical test for funnel plot asymmetry. The trim-and-fill technique estimates the number of missing studies and adjusts the pooled estimate accordingly.

Researchers should assess publication bias whenever they have a sufficient number of studies, typically ten or more. The assessment should be reported transparently, and the potential impact of publication bias on the conclusions should be discussed. Sensitivity analyses can explore how the results would change if unpublished studies were included.

Heterogeneity and Statistical Models

Heterogeneity refers to the variability in effect sizes across studies. Clinical heterogeneity includes variations in study populations, interventions, and outcomes. Statistical heterogeneity refers to the variability in effect sizes that cannot be explained by chance alone. Both types of heterogeneity require careful consideration.

Clinical heterogeneity is particularly problematic and requires careful consideration when defining inclusion and exclusion criteria. Studies that differ substantially in their populations, interventions, or outcomes may not be appropriate to combine. Researchers should define their eligibility criteria to minimize clinical heterogeneity while still including enough studies to conduct a meaningful meta-analysis.

Statistical heterogeneity is commonly quantified using the I² statistic, which describes the percentage of variability in effect sizes that is due to true heterogeneity instead of sampling error. When I² values are low, typically below 25 percent, fixed-effect models may be appropriate. When I² values are higher, random-effects models should be used to account for the diversity of included studies.

The choice between fixed-effect and random-effects models has important implications for the results. Fixed-effect models assume that all studies estimate the same underlying effect, while random-effects models assume that the true effect varies across studies. Random-effects models produce wider confidence intervals when heterogeneity is present, reflecting the additional uncertainty introduced by between-study variability.

The selection of appropriate statistical models is a common pitfall in meta-analysis. Researchers sometimes use fixed-effect models when random-effects models are more appropriate, leading to overly narrow confidence intervals and potentially misleading conclusions. Conversely, random-effects models may be used when fixed-effect models would be more appropriate, though this error is less common.

Statistical heterogeneity necessitates the use of random-effects models and sensitivity analyses to account for the diversity of included studies. The choice of statistical methods and the potential impact of outliers can significantly influence meta-analytic conclusions. Researchers should examine the influence of individual studies on the pooled estimate and consider whether outliers should be excluded or analyzed separately.

Inappropriate Pooling

Inappropriate pooling occurs when studies that are too dissimilar are combined into a single meta-analysis. This mistake can produce a summary effect that does not apply to any real population or clinical scenario. The pooled estimate may be statistically precise but clinically meaningless.

Meta-analysis is not always the appropriate method for synthesizing a body of literature. In sport and exercise science, the number of published meta-analyses has increased rapidly in recent years, raising important questions about when quantitative synthesis is appropriate and when meta-analysis may become the right tool at the wrong time. Meta-analysis offers a powerful tool for synthesizing data from multiple studies, but it is crucial to apply appropriate methodology to ensure the validity of results.

When meta-analysis is not appropriate, researchers should consider alternative approaches. Narrative synthesis can integrate the results of a systematic review focusing on textual data. This approach is appropriate when studies are too heterogeneous to combine statistically or when the data are insufficient for quantitative synthesis.

The decision to pool studies should be based on clinical and methodological judgment, not solely on statistical criteria. Researchers should ask whether the studies are sufficiently similar in terms of populations, interventions, comparators, and outcomes to justify combining them. If the answer is no, the meta-analysis should not be conducted.

Sensitivity Analysis and Trial Sequential Analysis

Sensitivity analyses test the robustness of meta-analytic results to methodological decisions. These analyses explore how the results change when different assumptions are made or when different subsets of studies are analyzed. Common sensitivity analyses include excluding studies at high risk of bias, using different statistical models, and examining the influence of individual studies.

Sensitivity analyses further validate the robustness of findings. If the results change substantially when a particular decision is altered, the conclusions should be interpreted with caution. Sensitivity analyses should be planned in advance and reported transparently.

Trial sequential analysis is a method that controls the risk of random errors and assesses whether the results in a meta-analysis are conclusive. This approach combines the information size required for a reliable conclusion with the cumulative evidence from included studies. Trial sequential analysis can identify false positive and false negative results that may occur when meta-analyses are conducted before sufficient evidence has accumulated.

Random error in meta-analyses is a common problem. False positive and false negative results can occur when the number of included studies or participants is insufficient to provide reliable estimates. Trial sequential analysis helps researchers determine whether their results are conclusive or whether additional studies are needed.

Common Failure Patterns in Meta-Analysis

Several failure patterns recur across meta-analyses in different fields. Recognizing these patterns can help researchers avoid them and help readers identify problematic meta-analyses.

One common failure pattern is the inclusion of studies with different designs in a single meta-analysis without adequate justification. Combining randomized trials with observational studies can produce misleading results because these designs have different susceptibility to bias. If both types of studies are included, they should be analyzed separately or the analysis should account for study design.

Another failure pattern is the use of inappropriate statistical models. Researchers sometimes use fixed-effect models when substantial heterogeneity is present, producing overly precise estimates that do not reflect the uncertainty in the evidence. The choice of model should be guided by the degree of heterogeneity and the assumptions about the underlying effect.

Data extraction errors represent another common failure pattern. These errors can be subtle and difficult to detect, but they can substantially alter the results of a meta-analysis. Double data extraction and verification of data entry can reduce the risk of these errors.

Overinterpretation of results is a pervasive problem. Meta-analyses that find statistically significant effects are sometimes interpreted as providing definitive answers, even when the certainty of the evidence is low. Researchers should assess the certainty of the evidence and draw conclusions that reflect the limitations of the available data.

The pitfalls of conventional methods of screening for systematic reviews include the challenge of identifying studies where relevant outcomes are not mentioned in the abstract. This problem is particularly acute for adverse events and rare complications, which are often omitted from abstracts due to word limits or pressure to publish. Researchers should be aware that their search and screening methods may miss relevant data and should take steps to mitigate this risk.

Heterogeneity Beyond Statistical Measures

Heterogeneity in meta-analysis extends beyond the I² statistic. Methodological differences across studies can introduce variability that is not captured by statistical measures of heterogeneity. These differences include variations in study design, measurement methods, and analytical approaches.

In preclinical imaging, for example, meta-analyses have demonstrated that reported cerebral blood flow values exhibit broad variability driven primarily by experimental confounds instead of physiological differences. Biological factors such as the choice of anesthesia and strain variations alter baseline measurements. This variability highlights the need to account for multiple sources of variability when conducting meta-analyses of preclinical data.

The choice of measurement methods can introduce heterogeneity that is difficult to quantify. Studies that use different instruments, different protocols, or different definitions of outcomes may produce results that are not directly comparable. Researchers should carefully evaluate the methods used in included studies and consider whether methodological differences are likely to affect the results.

In small-cohort settings, standard cross-validation can be overly optimistic. Studies with repeated runs from the same biological unit can produce inflated estimates of predictive accuracy. Grouped validation approaches that account for the clustering of data can provide more realistic estimates. These issues are relevant to meta-analyses that include studies with complex data structures.

Quality Assessment Tools and Their Limitations

The choice of quality assessment tools can influence the results of a meta-analysis. Different tools may produce different assessments of the same studies, and the results of the risk of bias assessment can affect which studies are included and how the results are interpreted.

The Cochrane Risk of Bias 2 tool is the recommended instrument for randomized controlled trials. This tool evaluates bias across several domains and provides a structured approach to assessing the risk of bias. The tool has been widely adopted and is considered the standard for randomized trials.

For nonrandomized studies, the Risk Of Bias In Non-randomized Studies tool and the Newcastle-Ottawa Scale are commonly used. The Newcastle-Ottawa Scale has been critically evaluated, and researchers should understand its limitations. The tool has been criticized for its lack of clear guidance on how to assess comparability and for the potential for subjectivity in scoring.

The choice of quality assessment tool should be justified in the review protocol. Researchers should describe the tools they used and explain why those tools were appropriate for the included study designs. The results of the quality assessment should be reported for each included study and considered when interpreting the results.

The EQUATOR Network provides reporting guidelines that can help researchers report their systematic reviews and meta-analyses transparently. Transparent reporting allows readers to evaluate the methods used and the potential for bias in the results.

Practical Steps for Conducting a Meta-Analysis

The following steps provide a practical framework for conducting a meta-analysis. These steps are based on established methods and are designed to minimize the risk of common errors.

First, formulate a well-defined research question using structured frameworks. The question should specify the population, intervention, comparator, and outcomes of interest. Document the question and eligibility criteria in a protocol before conducting the search.

Second, conduct comprehensive literature searches across multiple databases. Use controlled vocabulary terms and free-text terms to maximize sensitivity. Search PubMed, Embase, and the Cochrane Library, and supplement database searches with manual searching of reference lists and citation tracking.

Third, screen the identified records for eligibility. Screening should be conducted by two investigators independently, with disagreements resolved through discussion or consultation with a third reviewer. Document the screening process and report it transparently.

Fourth, assess the risk of bias of included studies using validated tools. Use the Cochrane Risk of Bias 2 tool for randomized trials and appropriate tools for nonrandomized studies. Report the results of the risk of bias assessment for each included study.

Fifth, extract data using standardized forms. Data extraction should be conducted by two researchers independently, with discrepancies resolved by consulting the original study. Verify data entry to minimize errors.

Sixth, assess heterogeneity using appropriate statistical measures. Calculate the I² statistic and consider the clinical and methodological heterogeneity of the included studies. Choose between fixed-effect and random-effects models based on the degree of heterogeneity.

Seventh, conduct the meta-analysis using appropriate statistical software. Software such as R and RevMan can compute effect sizes, confidence intervals, and assess heterogeneity. Verify that the data entered into the software match the data extracted from the studies.

Eighth, assess publication bias using funnel plots and statistical tests. Use Egger regression and the trim-and-fill technique when appropriate. Consider the potential impact of publication bias on the conclusions.

Ninth, conduct sensitivity analyses to test the robustness of the results. Exclude studies at high risk of bias, use different statistical models, and examine the influence of individual studies. Consider trial sequential analysis to assess whether the results are conclusive.

Tenth, assess the certainty of the evidence and draw conclusions that reflect the limitations of the available data. Interpret the results cautiously and avoid overinterpretation.

Records and Documentation

Maintaining detailed records throughout the meta-analysis process is essential for transparency and reproducibility. These records allow readers to evaluate the methods used and allow other researchers to replicate the review.

The protocol should document the research question, eligibility criteria, search strategy, and planned analyses. Any deviations from the protocol should be documented and explained.

The search records should document the databases searched, the search dates, and the search strategies used. The number of records identified, screened, excluded, and included should be reported, typically in a flow diagram.

The screening records should document the decisions made at each stage of screening. Reasons for exclusion should be recorded at the full-text stage.

The data extraction forms should document the data extracted from each study. These forms should be available for verification and should include all data used in the analysis.

The risk of bias assessments should be documented for each included study. The assessments should include the judgments made for each domain and the supporting information for those judgments.

The statistical analyses should be documented, including the software used, the commands or procedures applied, and the results of the analyses. This documentation allows other researchers to verify the analyses and assess their appropriateness.

Common Failure Patterns and How to Identify Them

Readers of meta-analyses should be alert to common failure patterns that indicate potential problems with the review. These patterns can be identified through careful evaluation of the methods and results.

One failure pattern is the absence of a clear research question or eligibility criteria. Meta-analyses that do not specify their question and criteria are difficult to evaluate and may have included studies inappropriately.

Another failure pattern is the use of a limited search strategy. Meta-analyses that search only one or two databases may have missed relevant studies. The search strategy should be reported in sufficient detail to allow evaluation.

A third failure pattern is the absence of risk of bias assessment. Meta-analyses that do not assess the risk of bias of included studies cannot account for the quality of the evidence. The risk of bias assessment should be reported for each included study.

A fourth failure pattern is the inappropriate use of statistical models. Meta-analyses that use fixed-effect models when substantial heterogeneity is present may produce overly precise estimates. The choice of model should be justified based on the degree of heterogeneity.

A fifth failure pattern is the absence of sensitivity analyses. Meta-analyses that do not test the robustness of their results to methodological decisions may be vulnerable to bias. Sensitivity analyses should be planned and reported.

A sixth failure pattern is the overinterpretation of results. Meta-analyses that present their findings as definitive when the certainty of the evidence is low may mislead readers. The conclusions should reflect the limitations of the available data.

Limitations of Meta-Analysis

Meta-analysis has important limitations that researchers and readers should understand. These limitations do not negate the value of meta-analysis but should inform the interpretation of results.

Meta-analysis cannot overcome the limitations of the included studies. If the primary studies are flawed, the meta-analysis will inherit those flaws. Risk of bias assessment can identify these flaws, but it cannot correct them.

Meta-analysis is vulnerable to publication bias. Studies with statistically significant results are more likely to be published than studies with nonsignificant results, and this bias can lead to overestimated treatment effects. Statistical methods can detect and adjust for publication bias, but they cannot fully correct for it.

Meta-analysis requires clinical and methodological judgment. The decision to pool studies, the choice of statistical models, and the interpretation of results all require judgment. Different researchers may make different decisions, leading to different results.

Meta-analysis can produce misleading numerical precision. When studies are heterogeneous or when the evidence base is limited, the pooled estimate may appear more precise than the underlying evidence warrants. Researchers should interpret the results with appropriate caution.

Meta-analysis is not always the appropriate method for synthesizing evidence. When studies are too heterogeneous, when the data are insufficient, or when the research question is not amenable to quantitative synthesis, alternative approaches may be more appropriate.

Safety and Regulatory Context

Meta-analyses can inform clinical guidelines and policy decisions. The results of meta-analyses are used to make recommendations about interventions, to identify gaps in the evidence, and to guide future research. Given this influence, the accuracy and reliability of meta-analyses are matters of public health importance.

Medication errors are a great concern to health care organizations as they are costly and pose a significant risk to patients. Children are three times more likely to be affected by medication errors than adults, with medication administration error rates reported to be over 70 percent. Systematic reviews and meta-analyses of interventions to reduce medication errors have identified education programs, medication information services, clinical pharmacist involvement, double checking, barriers to reduce interruptions during drug calculation and preparation, implementation of smart pumps, and improvement strategies as effective approaches. Meta-analysis has demonstrated an associated reduction in medicine administration errors post intervention. These findings have informed clinical practice and patient safety initiatives.

Meta-analyses of interventions to reduce medication errors in adult medical and surgical settings have shown that prescribing errors can be reduced by pharmacist-led medication reconciliation, computerized medication reconciliation, pharmacist partnership, prescriber education, medication reconciliation by trained mentors, and computerized physician order entry as single interventions. Medication administration errors can be reduced by computerized physician order entry and the use of automated drug distribution systems as single interventions. Combined interventions have also been found to be effective in reducing prescribing or administration medication errors. These findings have implications for patient safety and health care policy.

The results of meta-analyses can influence clinical guidelines and patient care. Biased evidence from meta-analyses can lead to inappropriate recommendations and harm to patients. Researchers have a responsibility to conduct meta-analyses rigorously and to report their methods and results transparently.

Professional Escalation Criteria

Researchers who encounter problems during the conduct of a meta-analysis should know when to escalate concerns to appropriate professionals. The following situations warrant consultation with a statistician, methodologist, or other expert.

If the heterogeneity of the included studies is substantial and difficult to explain, consultation with a statistician may be appropriate. A statistician can help identify sources of heterogeneity and recommend appropriate analytical approaches.

If the data extraction reveals inconsistencies or errors in the primary studies, consultation with the study authors or a methodologist may be appropriate. Clarifying the data with the study authors can prevent errors in the meta-analysis.

If the risk of bias assessment reveals serious flaws in the included studies, consultation with a methodologist may be appropriate. A methodologist can help determine whether the studies should be included and how the risk of bias should be addressed in the analysis.

If the results of the meta-analysis are surprising or inconsistent with the existing literature, consultation with a content expert may be appropriate. A content expert can help interpret the results and identify potential explanations for the findings.

If the meta-analysis is intended to inform clinical guidelines or policy decisions, consultation with relevant stakeholders may be appropriate. The results should be presented in a way that is accessible and useful to decision makers.

Frequently Asked Questions

What is the difference between a systematic review and a meta-analysis?

A systematic review is a type of literature review that uses a systematic process to identify and assess all available literature on a specific research question. A meta-analysis is a statistical method of synthesizing the results of a systematic review by quantitatively combining data. Not all systematic reviews include a meta-analysis, but a meta-analysis should be based on a systematic review to ensure that all relevant studies are identified and assessed.

When is meta-analysis not appropriate?

Meta-analysis is not appropriate when the included studies are too heterogeneous to combine meaningfully, when the data are insufficient for quantitative synthesis, or when the research question is not amenable to quantitative synthesis. In these situations, narrative synthesis or other approaches may be more appropriate. Meta-analysis may become the right tool at the wrong time when the evidence base is too limited or too diverse to support quantitative pooling.

How can publication bias be detected and addressed?

Publication bias can be detected using funnel plots, which provide a visual assessment of the relationship between effect sizes and study precision. Egger regression provides a statistical test for funnel plot asymmetry. The trim-and-fill technique estimates the number of missing studies and adjusts the pooled estimate accordingly. Researchers should assess publication bias whenever they have a sufficient number of studies and should discuss the potential impact of publication bias on their conclusions.

What is heterogeneity and why does it matter?

Heterogeneity refers to the variability in effect sizes across studies. Clinical heterogeneity includes variations in study populations, interventions, and outcomes. Statistical heterogeneity refers to the variability in effect sizes that cannot be explained by chance alone. Heterogeneity matters because it affects the choice of statistical model and the interpretation of the pooled estimate. When heterogeneity is substantial, random-effects models should be used and the results should be interpreted with caution.

What is the difference between fixed-effect and random-effects models?

Fixed-effect models assume that all studies estimate the same underlying effect, while random-effects models assume that the true effect varies across studies. Fixed-effect models produce narrower confidence intervals when heterogeneity is low, while random-effects models produce wider confidence intervals when heterogeneity is present. The choice of model should be based on the degree of heterogeneity and the assumptions about the underlying effect.

What is trial sequential analysis?

Trial sequential analysis is a method that controls the risk of random errors and assesses whether the results in a meta-analysis are conclusive. This approach combines the information size required for a reliable conclusion with the cumulative evidence from included studies. Trial sequential analysis can identify false positive and false negative results that may occur when meta-analyses are conducted before sufficient evidence has accumulated.

What are the most common data extraction errors in meta-analysis?

Common data extraction errors include data entry mistakes, incorrect calculation of effect sizes, and extraction of data from the wrong tables or figures. These errors can lead to incorrect pooled estimates and conclusions. Data extraction should use standardized forms and should be conducted by two researchers independently to reduce the risk of errors.

How should risk of bias be assessed in a meta-analysis?

Risk of bias should be assessed using validated tools appropriate for the study designs included in the review. The Cochrane Risk of Bias 2 tool is recommended for randomized controlled trials, while the Risk Of Bias In Non-randomized Studies tool and the Newcastle-Ottawa Scale are commonly used for nonrandomized studies. The results of the risk of bias assessment should be reported for each included study and considered when interpreting the results.

Related Articles

• CRISPR Off-Target Analysis And Validation Planning
• CRISPR Off-Target Analysis And Validation Planning
• CRISPR Off-Target Analysis And Validation Planning
• Multiple Sequence Alignment: Common Pitfalls and Quality Checks
• Responding to Peer Review: A Structured Revision and Response Process

References and Further Reading

• Research Data Framework. National Institute of Standards and Technology.
• EQUATOR Network. EQUATOR Network.
• Experimental Design Assistant. NC3Rs.
• NCBI Literature Resources. National Center for Biotechnology Information.
• PubMed. National Library of Medicine.
• Nursing interventions to reduce medication errors in paediatrics and neonates: Systematic review and meta-analysis.. Journal of pediatric nursing, 2022.
• A comprehensive guide to conduct a systematic review and meta-analysis in medical research.. Medicine, 2025.
• Interventions for myopia control in children: a living systematic review and network meta-analysis.. The Cochrane database of systematic reviews, 2023.
• Interventions to reduce medication errors in adult medical and surgical settings: a systematic review.. Therapeutic advances in drug safety, 2020.
• Genetic epidemiology of major depression: review and meta-analysis.. The American journal of psychiatry, 2000.
• Timing of renal replacement therapy initiation for acute kidney injury in critically ill patients: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis.. Critical care (London, England), 2021.
• Systematic reviews of the literature: an introduction to current methods.. American journal of epidemiology, 2025.
• Association between digital smart device use and myopia: a systematic review and meta-analysis.. The Lancet. Digital health, 2021.
• Pitfalls in meta-analysis.. 2020.
• Heterogeneity and Beyond: Unaddressed Pitfalls in the Meta-Analysis of Advanced CTA for MACE Prediction.. 2026.
• REPLY: Heterogeneity and Beyond: Unaddressed Pitfalls in the Meta-Analysis of Advanced CTA for MACE Prediction.. 2026.
• Opportunities and pitfalls in preclinical cerebral blood flow mapping using arterial spin labelling MRI: insights from multicentre data. 2026.
• Integrating Mutation-Derived and Expression Features from Single-Cell RNA Sequencing: Pitfalls of Standard Cross-Validation in Small-Cohort Settings.. 2026.
• Meta-analyses in sport and exercise science: sometimes the right tool at the wrong time?. 2026.
• The pitfalls of conventional methods of screening for systematic reviews: Lessons learned.. 2026.
• A review of the status, challenges, trends, and prospects of groundwater quality assessment in Nigeria: an evidence-based meta-analysis approach. Environmental science and pollution research international, 2024.
• Enhancing study quality assessment: an in-depth review of risk of bias tools for meta-analysis-a comprehensive guide for anesthesiologists. Journal of Anesthesia Analgesia and Critical Care, 2023.
• Systematic review and meta-analysis.. Medicina Intensiva, 2017.
• Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology, 2010.
• With Great Power Comes Great Responsibility: Common Errors in Meta-Analyses and Meta-Regressions in Strength & Conditioning Research. Sports Medicine, 2023.
• Common Errors in Sports Nutrition Meta-Analyses Lead to Distortion of Pooled Effect Estimates. Comment on Viribay et al. Effects of Arginine Supplementation on Athletic Performance Based on Energy Metabolism: A Systematic Review and Meta-Analysis. Nutrients 2020, 12, 1300. Nutrients, 2025.
• Random error in cardiovascular meta-analyses: How common are false positive and false negative results?. International Journal of Cardiology, 2013.
• Challenges and limitations in meta-analyses of complications in neurosurgery: Systematic review with proposed approach and checklist to mitigate errors and improve the assessment of the real-world experience. Neurosurgical Review, 2024.
• Development of a checklist to detect errors in meta-analyses in systematic reviews of interventions: Study protocol. F1000research, 2021.

This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.